Michael Lamb
Nurse Practitioner · Ocala, FLNPI 1356607196
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 176 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 15.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,362, 2.5 times the $544 reported in 2021. Among nurse practitioner clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 176 payments — averaging $22.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$607
- Merck$443
- Insmed, Inc.$363
- Averitas Pharma Inc.$339
- Theratechnologies Inc.$310
- Aimmune Therapeutics, Inc.$264
- plus $2K from 27 others
What the payments were for
- Food & beverage$3,90799%
- Education$231%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 22 | $607 |
| Merck | 24 | $443 |
| Insmed, Inc. | 19 | $363 |
| Averitas Pharma Inc. | 9 | $339 |
| Theratechnologies Inc. | 12 | $310 |
| Aimmune Therapeutics, Inc. | 10 | $264 |
| Johnson & Johnson(2 entities) | 16 | $250 |
| Viiv Healthcare Company | 7 | $182 |
| Smith+Nephew | 7 | $180 |
| AbbVie | 7 | $133 |
| Paratek Pharmaceuticals, Inc. | 7 | $117 |
| Mimedx Group, Inc. | 5 | $101 |
| Melinta Therapeutics, LLC | 4 | $69 |
| Bioventus LLC | 2 | $55 |
| Pfizer | 3 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $44 |
| Reprise Biomedical, Inc. | 2 | $43 |
| Medtronic | 1 | $36 |
| Integra Lifesciences Corporation | 1 | $32 |
| Tactile Systems Technology Inc | 1 | $30 |
| Cumberland Pharmaceuticals, Inc. | 1 | $30 |
| Acera Surgical, Inc. | 2 | $28 |
| Shionogi Inc | 1 | $26 |
| Mayne Pharma Commercial LLC | 2 | $25 |
| Medline Industries LP | 1 | $23 |
| Molnlycke Health Care US, LLC | 1 | $22 |
| Convatec Inc. | 1 | $22 |
| Urgo Medical North America, LLC | 1 | $20 |
| Cipher Pharmaceuticals US LLC | 1 | $19 |
| Hydrofera LLC | 1 | $18 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
| Solventum Corporation | 1 | $15 |
| Lifenet Health | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Biktarvy$124
How this compares
$3,930 in reported general payments places this provider in the 90th percentile of 8,290 nurse practitioner providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 24 | $93,448 |
| Efavirenz-Emtric-Tenofov DisopEfavirenz/Emtricit/Tenofovr Df | 12 | $25,688 |
| Vancomycin Hcl | 19 | $5,442 |
| Daptomycin | 12 | $2,667 |
| CeftriaxoneCeftriaxone Sodium | 18 | $2,190 |
| Doxycycline Hyclate | 39 | $1,246 |
| Ciprofloxacin Hcl | 11 | $147 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy | $607 | $93,44824 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,290 nurse practitioner providers in Florida.
Other nurse practitioner in Ocala
- Jolanta BaginskiClearwater$494K
- Adissa PerezWinter Park$370K
- April WessonTampa$342K
- Margarita FernandezMiami$311K
- Stephanie SimmermanNaples$283K
- Claudette WalkerPonte Vedra Beach$271K
- Lisa NodzonTampa$246K
- Ashima BahlTampa$226K
- Maya BloombergMiami$202K
- Jennifer PuleoTampa$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.